GlassScriptPhysician profile
Kerry Berg
NPI 1831196815
$3,760.35
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $46.01 · 2021: $12.11 · 2022: $1,716 · 2023: $556 · 2024: $1,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927 · Travel and Lodging: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.96 |
| Travel and Lodging | $817.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $1,149.34 | 2024 | Acumed, Inframe Implant |
| Stryker Corporation | $1,065.66 | 2022 | |
| Horizon Therapeutics Plc | $297.38 | 2019-2023 | Krystexxa |
| Averitas Pharma INC. | $290.92 | 2023 | Qutenza |
| Anika Therapeutics, INC. | $256.96 | 2022 | |
| Grt US Holding, INC. | $214.86 | 2022 | |
| Axogen | $193.74 | 2019 | |
| Osteomed LLC | $119.88 | 2022 | |
| Orthofix Medical, INC. | $73.60 | 2022-2024 | Physio-Stim |
| Musculoskeletal Transplant Foundation INC. | $46.01 | 2020 | |
| Treace Medical Concepts, INC. | $24.18 | 2022 | |
| Smith+Nephew, INC. | $15.71 | 2019 | |
| Bioventus LLC | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.